Omnitrope®
Is a brand name for a synthetic form of human growth hormone (HGH) manufactured by Sandoz, a division of Novartis. It is a prescription medication used to treat various growth-related disorders in children and adults. Here’s a detailed description of Omnitrope:
| 2-10mg Vials | $1,360.00 | Total 30 IU |
| 5-10mg Vials | $3,060.00 | Total 150 IU |
| 8-10mg Vials | $4,780.00 | Total 240 IU |
| 1-15mg Vials | $1,060.00 | Total 45 IU |
| 3-15mg Vials | $2,760.00 | Total 135 IU |
| 5-15mg Vials | $4,310.00 | Total 225 IU |
Storage Omnitrope®
Omnitrope should be stored at controlled room temperature between 2°C and 8°C (36°F and 46°F) before reconstitution. After reconstitution, the solution should be used immediately or refrigerated at 2°C to 8°C (36°F to 46°F) and used within 14 days. Care should be taken to avoid freezing or shaking the medication.
Omnitrope® is typically administered via subcutaneous injection. The dosage and frequency of administration depend on the patient’s age, weight, and the condition being treated. It’s important for patients to receive proper training on how to self-administer the injections or have a caregiver who can assist them.
Omnitrope® contains somatropin, which is a synthetic form of human growth hormone (hGH). Somatropin is identical to the naturally occurring growth hormone produced by the pituitary gland.
Omnitrope® contains somatropin, which is a synthetic form of human growth hormone (hGH). Somatropin is identical to the naturally occurring growth hormone produced by the pituitary gland.
The dosage of Omnitrope
varies depending on the individual’s needs and the condition being treated. For pediatric patients with growth hormone deficiency, the initial dosage is typically 0.16 to 0.24 mg/kg body weight per week, divided into daily injections. For adults with growth hormone deficiency, the recommended dosage is generally 0.15 to 0.3 mg/day, administered as a daily injection.
some Side Effects
Common side effects of Omnitrope may include injection site reactions (pain, redness, bruising), headaches, joint pain, muscle pain, swelling in the hands or feet, and numbness or tingling. More serious side effects such as allergic reactions, pancreatitis, and intracranial hypertension are rare but possible.
some Side Effects
Patients receiving Omnitrope therapy require regular monitoring by a healthcare professional to assess growth velocity (in pediatric patients), hormone levels, and potential side effects. Adjustments to dosage may be necessary based on these evaluations.
Precautions
Special caution should be exercised when prescribing Omnitrope to patients with a history of intracranial lesions, diabetes mellitus, or other underlying medical conditions. Close monitoring of glucose levels is recommended in patients with diabetes.
Contraindications
Omnitrope should not be used in patients with active malignancy, diabetic retinopathy, acute critical illness, or hypersensitivity to somatropin or any of the ingredients in the formulation.